Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CGS | ISIN: US4618741098 | Ticker-Symbol:
NASDAQ
14.11.24
21:21 Uhr
10,400 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
INVIZYNE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
INVIZYNE TECHNOLOGIES INC 5-Tage-Chart

Aktuelle News zur INVIZYNE TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiInvizyne Technologies, Inc.: Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing56Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
► Artikel lesen
MiInvizyne Technologies stock climbs 13% following $15M IPO6
MiInvizyne Technologies Opens At $11.10, IPO Priced At $85
INVIZYNE TECHNOLOGIES Aktie jetzt für 0€ handeln
MiInvizyne Technologies, Inc.: Invizyne Technologies Begins Trading on NASDAQ60Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
► Artikel lesen
DiInvizyne Technologies Inc - 10-Q, Quarterly Report-
DiInvizyne Technologies, Inc.: Invizyne Technologies to Begin Trading on NASDAQ on November 13, 202450Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
► Artikel lesen
DiBiomanufacturing company Invizyne Technologies prices IPO at $85
DiInvizyne Technologies prices $15M U.S. IPO7
21.10.Invizyne Technologies Inc - S-1/A, General form for registration of securities1
05.10.Invizyne Cuts IPO Size And Lifts Offering Price1.061WASHINGTON (dpa-AFX) - Invizyne Technologies announced that it has decreased the size of shares and increased the price range of its planned initial public offering.The company, which develops...
► Artikel lesen
05.10.Biomanufacturing company Invizyne Technologies increases range and decreases shares ahead of $15 IPO deal size3
04.10.Invizyne Technologies Inc - S-1/A, General form for registration of securities4
19.09.Invizyne Technologies Inc - S-1/A, General form for registration of securities4
07.09.Biomanufacturing company Invizyne Technologies cuts share offering by 13% and adds rights ahead of $15 million IPO1
06.09.Invizyne Technologies Inc - S-1/A, General form for registration of securities1
01.08.Invizyne Technologies Inc - 8-A12B, Registration of securities-
01.08.Invizyne Technologies Inc - S-1/A, General form for registration of securities1
11.07.MDB Capital Holdings, LLC: MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies1
22.05.Invizyne Technologies Inc - S-1/A, General form for registration of securities1
07.05.Invizyne Technologies, Inc.: Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq3Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exitsAdditional industry veterans join in key roles including...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1